28 results
424B4
CNSP
Cns Pharmaceuticals Inc
31 Jan 24
Prospectus supplement with pricing info
4:27pm
agreements with us. If a conflict of interest arises between their work for us and their work for another entity, we may lose their services. In addition, our … benefit, or lack thereof, to us; (iv) the opportunity cost of alternate transactions; and (v) the actual or apparent conflict of interest of the related
8-K
EX-10.2
cg2kkcu xq
1 Dec 22
CNS Pharmaceuticals Announces Pricing of $6.0 Million Public Offering At a Premium to the Market Closing Price
5:19pm
8-K
EX-10.3
fjpi7ldn
6 Jan 22
CNS Pharmaceuticals Announces $11.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
9:11am
8-K
EX-10.2
gde6c4c la6
6 Jan 22
CNS Pharmaceuticals Announces $11.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
9:11am
PRE 14A
397pyjhoqf7 w3q6kd7x
27 May 21
Preliminary proxy
5:17pm